Biotech Values

[DewDiligence]

Took a while for this program to see the light of day, as long trials are needed for determining efficacy. Thanks for posting this.

The long delay may have been caused in part by controversy within Genentech (see masterlongevity’s comments in #msg-91454309) as well as some lingering resentment of Tanox stemming from an especially nasty litigation over the rights to Xolair (#msg-2517727, #msg-5951137).

In any case, a treatment for dry AMD is a major unmet medical need.